Home » Author Archive

Image for Nucor Corporation (NYSE:NUE) Stock Has Consensus Price Target of $276.07 According to Analysts

Nucor Corporation (NYSE:NUE) Stock Has Consensus Price Target of $276.07 According to Analysts

Nucor Corporation (NYSE:NUE – Get Free Report) has received a consensus rating of “Moderate Buy” from the seventeen analysts that are covering the stock, MarketBeat.com reports. Four investment analysts have rated... More of this article »
Image for Analyzing Murata Manufacturing (OTCMKTS:MRAAY) and Microvision (NASDAQ:MVIS)

Analyzing Murata Manufacturing (OTCMKTS:MRAAY) and Microvision (NASDAQ:MVIS)

Microvision (NASDAQ:MVIS – Get Free Report) and Murata Manufacturing (OTCMKTS:MRAAY – Get Free Report) are both technology companies, but which is the superior business? We will compare the two businesses based on the strength... More of this article »
Image for Alibaba Group Holding Limited (NYSE:BABA) Stock Has Average Target Price of $187.05 According to Brokerages

Alibaba Group Holding Limited (NYSE:BABA) Stock Has Average Target Price of $187.05 According to Brokerages

Shares of Alibaba Group Holding Limited (NYSE:BABA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty brokerages that are currently covering the stock, Marketbeat Ratings... More of this article »
Image for Contrasting Super Micro Computer (NASDAQ:SMCI) and Intchains Group (NASDAQ:ICG)

Contrasting Super Micro Computer (NASDAQ:SMCI) and Intchains Group (NASDAQ:ICG)

Intchains Group (NASDAQ:ICG – Get Free Report) and Super Micro Computer (NASDAQ:SMCI – Get Free Report) are both technology companies, but which is the superior investment? We will compare the two businesses based on the... More of this article »
Image for Mainz Biomed (NASDAQ:MYNZ) versus BETA Technologies (NYSE:BETA) Financial Analysis

Mainz Biomed (NASDAQ:MYNZ) versus BETA Technologies (NYSE:BETA) Financial Analysis

BETA Technologies (NYSE:BETA – Get Free Report) and Mainz Biomed (NASDAQ:MYNZ – Get Free Report) are both industrials companies, but which is the superior stock? We will compare the two businesses based on the strength... More of this article »
Image for Texas Roadhouse, Inc. (NASDAQ:TXRH) Stock Now Rated “Moderate Buy” by Wall Street Brokerages

Texas Roadhouse, Inc. (NASDAQ:TXRH) Stock Now Rated “Moderate Buy” by Wall Street Brokerages

Texas Roadhouse, Inc. (NASDAQ:TXRH – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-three research firms that are currently covering the firm, MarketBeat Ratings reports.... More of this article »
Image for Critical Survey: Aktis Oncology (NASDAQ:AKTS) vs. Bicycle Therapeutics (NASDAQ:BCYC)

Critical Survey: Aktis Oncology (NASDAQ:AKTS) vs. Bicycle Therapeutics (NASDAQ:BCYC)

Aktis Oncology (NASDAQ:AKTS – Get Free Report) and Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based... More of this article »
Image for Coca Cola Femsa S.A.B. de C.V. (NYSE:KOF) Stock Now Rated “Hold” by Sell-Side Analysts

Coca Cola Femsa S.A.B. de C.V. (NYSE:KOF) Stock Now Rated “Hold” by Sell-Side Analysts

Coca Cola Femsa S.A.B. de C.V. (NYSE:KOF – Get Free Report) has received a consensus rating of “Hold” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Five research analysts... More of this article »
Image for NBT Bancorp Inc. (NASDAQ:NBTB) Stock Rated “Hold” by Sell-Side Brokerages

NBT Bancorp Inc. (NASDAQ:NBTB) Stock Rated “Hold” by Sell-Side Brokerages

Shares of NBT Bancorp Inc. (NASDAQ:NBTB – Get Free Report) have received an average recommendation of “Hold” from the eight research firms that are presently covering the company, MarketBeat.com reports. Five investment... More of this article »
Image for PrairieSky Royalty Ltd. (TSE:PSK) Stock Has Average Target Price of C$34.42

PrairieSky Royalty Ltd. (TSE:PSK) Stock Has Average Target Price of C$34.42

Shares of PrairieSky Royalty Ltd. (TSE:PSK – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Two equities... More of this article »
Image for Intensity Therapeutics Inc. (NASDAQ:INTS) Stock Has Consensus Target Price of $7.00 According to Analysts

Intensity Therapeutics Inc. (NASDAQ:INTS) Stock Has Consensus Target Price of $7.00 According to Analysts

Shares of Intensity Therapeutics Inc. (NASDAQ:INTS – Get Free Report) have received an average recommendation of “Moderate Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. One... More of this article »
Image for Promising Solar Stocks To Research – October 4th

Promising Solar Stocks To Research – October 4th

First Solar, Solaris Energy Infrastructure, Nextpower, Enphase Energy, and SolarEdge Technologies are the five Solar stocks to watch today, according to MarketBeat’s stock screener tool. Solar stocks are shares of publicly... More of this article »
Image for Promising Mining Stocks Worth Watching – October 4th

Promising Mining Stocks Worth Watching – October 4th

Caterpillar, IREN, BitMine Immersion Technologies, Freeport-McMoRan, and Vale are the five Mining stocks to watch today, according to MarketBeat’s stock screener tool. Mining stocks are shares of companies involved in extracting... More of this article »
Image for JPMorgan European Growth & Income (LON:JEGI) Sets New 12-Month High – What’s Next?

JPMorgan European Growth & Income (LON:JEGI) Sets New 12-Month High – What’s Next?

JPMorgan European Growth & Income (LON:JEGI – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday. The company traded as high as GBX 169.20 and last traded at GBX 139.20, with a volume... More of this article »
Image for Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test

Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test

Inventiva (NASDAQ:IVA) said it expects to report top-line results in the fourth quarter of 2026 from its fully enrolled Phase III NATiV3 trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, or MASH. Chief... More of this article »
Image for Nextpower (NASDAQ:NXT) Raised to Hold at TD Cowen

Nextpower (NASDAQ:NXT) Raised to Hold at TD Cowen

Nextpower (NASDAQ:NXT – Get Free Report) was upgraded by research analysts at TD Cowen to a “hold” rating in a research note issued on Monday, Zacks reports. NXT has been the subject of several other research reports.... More of this article »
Image for Mizuho Issues Positive Forecast for Dell Technologies (NYSE:DELL) Stock Price

Mizuho Issues Positive Forecast for Dell Technologies (NYSE:DELL) Stock Price

Dell Technologies (NYSE:DELL – Free Report) had its target price upped by Mizuho from $600.00 to $650.00 in a research report report published on Tuesday morning, MarketBeat reports. The firm currently has an outperform rating... More of this article »
Image for FY2027 Earnings Forecast for AESI Issued By Scotiabank

FY2027 Earnings Forecast for AESI Issued By Scotiabank

Atlas Energy Solutions Inc. (NYSE:AESI – Free Report) – Investment analysts at Scotiabank issued their FY2027 EPS estimates for Atlas Energy Solutions in a research note issued on Thursday, October 1st. Scotiabank analyst... More of this article »
Image for Fevertree Drinks (LON:FEVR) Stock Price Target Lowered at Deutsche Bank Aktiengesellschaft

Fevertree Drinks (LON:FEVR) Stock Price Target Lowered at Deutsche Bank Aktiengesellschaft

Fevertree Drinks (LON:FEVR – Free Report) had its price objective cut by Deutsche Bank Aktiengesellschaft from GBX 900 to GBX 870 in a report released on Tuesday,Digital Look reports. They currently have a hold rating on the... More of this article »
Image for Consumer Portfolio Services (NASDAQ:CPSS) Rating Lowered to Hold at Wall Street Zen

Consumer Portfolio Services (NASDAQ:CPSS) Rating Lowered to Hold at Wall Street Zen

Consumer Portfolio Services (NASDAQ:CPSS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Monday, Wall Street Zen... More of this article »
Image for Klarna Group (NYSE:KLAR) Raised to Hold at Wall Street Zen

Klarna Group (NYSE:KLAR) Raised to Hold at Wall Street Zen

Klarna Group (NYSE:KLAR – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Monday, Wall Street Zen reports. Other analysts... More of this article »
Image for iShares U.S. Oil & Gas Exploration & Production ETF (BATS:IEO) Stock Jumps 0.6% – Still a Buy?

iShares U.S. Oil & Gas Exploration & Production ETF (BATS:IEO) Stock Jumps 0.6% – Still a Buy?

iShares U.S. Oil & Gas Exploration & Production ETF (BATS:IEO – Get Free Report)’s share price were up 0.6% during mid-day trading on Tuesday. The stock traded as high as $140.18 and last traded at $139.68. Approximately... More of this article »
Image for Lifeway Foods (NASDAQ:LWAY) Major Shareholder Divisadero Street Capital Mana Buys 50,000 Shares of Company Stock

Lifeway Foods (NASDAQ:LWAY) Major Shareholder Divisadero Street Capital Mana Buys 50,000 Shares of Company Stock

Lifeway Foods, Inc. (NASDAQ:LWAY – Get Free Report) major shareholder Divisadero Street Capital Mana bought 50,000 shares of the firm’s stock in a transaction dated Tuesday, October 6th. The stock was acquired at an average... More of this article »
Image for Insider Buying: Lifeway Foods (NASDAQ:LWAY) Major Shareholder Buys 17,482 Shares of Stock

Insider Buying: Lifeway Foods (NASDAQ:LWAY) Major Shareholder Buys 17,482 Shares of Stock

Lifeway Foods, Inc. (NASDAQ:LWAY – Get Free Report) major shareholder Divisadero Street Capital Mana bought 17,482 shares of the stock in a transaction dated Friday, October 2nd. The shares were acquired at an average cost of... More of this article »
Image for SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,133 Shares of Company Stock

SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,133 Shares of Company Stock

SiBone (NASDAQ:SIBN – Get Free Report) SVP Michael Pisetsky sold 3,133 shares of the business’s stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $18.17, for a total transaction... More of this article »